APA引文

An, Q., Wang, H., Zhu, H., Jia, Y., Liu, Y., Liu, Z., . . . Zhou, Z. (2025, July). Nomogram-based risk stratification to analyze the value of receiving postoperative adjuvant therapy after neoadjuvant immunochemotherapy for patients with locally advanced esophageal squamous carcinoma. Frontiers in Immunology.

Chicago Style (17th ed.) Citation

An, Qiuying, et al. "Nomogram-based Risk Stratification to Analyze the Value of Receiving Postoperative Adjuvant Therapy After Neoadjuvant Immunochemotherapy for Patients with Locally Advanced Esophageal Squamous Carcinoma." Frontiers in Immunology Jul. 2025.

MLA引文

An, Qiuying, et al. "Nomogram-based Risk Stratification to Analyze the Value of Receiving Postoperative Adjuvant Therapy After Neoadjuvant Immunochemotherapy for Patients with Locally Advanced Esophageal Squamous Carcinoma." Frontiers in Immunology, Jul. 2025.

警告:這些引文格式不一定是100%准確.